Complete Filing Data
Zapata Quantum, Inc. reported Stockholders Equity of -$8.27 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Zapata Quantum, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net Income * | $9.3M | -$38.1M | -$29.7M | $1.9M | -$10.9K |
| Operating Income Loss | -$3.4M | -$23.0M | -$18.1M | -$1.5M | -$10.9K |
| Nonoperating Income Expense | $12.8M | -$15.1M | -$11.6M | $3.4M | |
| Interest Expense | $513.0K | $962.0K | $70.9K | $0.00 | |
| Operating Expenses | $3.4M | $23.7M | $19.2M | ||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $9.3M | -$38.1M | -$29.7M | ||
| General And Administrative Expense | $2.9M | $12.1M | $7.4M | ||
| Comprehensive Income Net Of Tax | $9.3M | -$38.2M | -$29.8M | ||
| Selling And Marketing Expense | $267.0K | $7.1M | $5.9M | ||
| Other Nonoperating Income Expense | $48.0K | -$1.9M | $37.0K | ||
| Research And Development Expense | $252.0K | $4.4M | $5.9M | ||
| Revenues | $3.9M | $5.7M | |||
| Income Tax Expense Benefit | $20.0K | $20.0K | |||
| Gross Profit | $635.0K | $1.1M | |||
| Cost Of Revenue | $3.2M | $4.6M | |||
| Deferred Revenue Current | $406.0K | $406.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | $3.3M | $2.7M | -$770.0K | $3.5M | -$15.6M | -$22.3M | -$5.4M | -$4.7M | -$5.1M | $684.3K | -$47.6K | -$276.5K | -$225.00 | -$4.2K | -$5.0K | |
| Operating Income Loss | -$1.0M | -$584.0K | -$680.0K | -$7.6M | -$7.4M | -$5.1M | -$4.9M | -$4.1M | -$5.1M | -$386.9K | -$360.0K | -$298.2K | -$225.00 | -$4.2K | -$5.0K | |
| Nonoperating Income Expense | $4.3M | $3.3M | -$90.0K | $11.1M | -$8.2M | -$17.2M | -$502.0K | -$558.0K | $29.0K | $1.1M | $312.5K | $21.8K | ||||
| Interest Expense | $136.0K | $141.0K | $102.0K | $55.0K | $77.0K | $784.0K | $24.6K | $0.00 | $0.00 | $0.00 | ||||||
| Operating Expenses | $1.0M | $584.0K | $680.0K | $7.4M | $8.1M | $5.2M | $5.0M | $4.4M | $5.3M | |||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $3.3M | $2.7M | -$770.0K | $3.5M | -$15.6M | -$22.3M | -$5.4M | -$4.7M | -$5.1M | |||||||
| General And Administrative Expense | $1.0M | $584.0K | $680.0K | $3.9M | $4.3M | $2.2M | $2.2M | $1.3M | $1.5M | |||||||
| Comprehensive Income Net Of Tax | $3.3M | $2.7M | -$784.0K | $3.5M | -$15.6M | -$22.3M | -$5.4M | -$4.7M | -$5.1M | |||||||
| Selling And Marketing Expense | $6.0K | $2.1M | $2.2M | $1.6M | $1.3M | $1.6M | $1.7M | |||||||||
| Other Nonoperating Income Expense | $13.0K | $5.0K | $12.0K | -$210.0K | $108.0K | -$1.7M | -$502.0K | -$558.0K | $29.0K | |||||||
| Research And Development Expense | $1.4M | $1.6M | $1.4M | $1.5M | $1.5M | $2.1M | ||||||||||
| Revenues | $657.0K | $2.0M | $1.2M | $1.4M | $1.4M | $1.5M | ||||||||||
| Income Tax Expense Benefit | $7.0K | $7.0K | $6.0K | $2.0K | $23.0K | $4.0K | ||||||||||
| Gross Profit | -$256.0K | $721.0K | $166.0K | $188.0K | $282.0K | $206.0K | ||||||||||
| Cost Of Revenue | $913.0K | $1.3M | $1.1M | $1.2M | $1.2M | $1.3M | ||||||||||
| Deferred Revenue Current | $406.0K | $406.0K | $406.0K | $1.1M | $736.0K | $650.0K | $744.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Stockholders Equity | -$8.3M | -$23.5M | -$10.2M | $14.1K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $1.7M | $359.0K | $3.5M | $0.00 | |
| Liabilities | $10.5M | $26.2M | $8.3M | $583.5K | |
| Repayments Of Related Party Debt | $635.0K | $0.00 | $240.6K | $0.00 | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $1.3M | -$3.1M | -$6.7M | $616.1K | $0.00 |
| Temporary Equity Accretion To Redemption Value | $8.2M | $38.7M | |||
| Retained Earnings Accumulated Deficit | -$118.3M | -$127.7M | -$7.1M | -$10.9K | |
| Prepaid Expense And Other Assets Current | $181.0K | $229.0K | $590.9K | $2.0K | |
| Liabilities And Stockholders Equity | $2.3M | $2.7M | $240.4M | $597.6K | |
| Assets Current | $1.8M | $2.2M | $1.2M | $2.0K | |
| Assets | $2.3M | $2.7M | $240.4M | $597.6K | |
| Liabilities Current | $10.5M | $23.7M | $115.3K | $583.5K | |
| Assets Held In Trust Noncurrent | $86.3M | $239.1M | $0.00 | ||
| Offering Costs Included In Accounts Payable Accrued Expenses | $0.00 | $85.0K | $343.0K | ||
| Deferred Under Writing Fees Payable | $0.00 | $8.1M | $0.00 | ||
| Temporary Equity Carrying Amount Attributable To Parent | $86.3M | $239.1M | $0.00 | ||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | ||
| Deferred Underwriting Fee Payable Non Current | $8.1M | $8.1M | $0.00 | ||
| Deferred Offering Costs Non Current | $0.00 | $595.6K | |||
| Accrued Offering Costs Current | $0.00 | $85.0K | $343.0K | ||
| Deferred Legal Fee Non Current | $4.0M | $160.0K | $0.00 | ||
| Deferred Legal Fees Current | $2.6M | ||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$162.0K | -$109.0K | |||
| Accounts Payable Current | $4.0M | $14.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$16.1M | -$19.4M | -$24.2M | -$19.8M | -$27.0M | -$21.1M | -$71.6M | -$66.7M | -$62.1M | -$57.1M | -$6.6M | -$6.2M | -$5.9M | $15.6K | $15.8K | $20.0K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $919.0K | $1.4M | $288.0K | $3.2M | $7.3M | $7.4M | $3.5M | $6.1M | $4.9M | $10.2M | $807.6K | $962.3K | $1.2M | $0.00 | $0.00 | $0.00 | |
| Liabilities | $19.4M | $23.1M | $26.8M | $26.4M | $38.1M | $8.2M | $18.3M | $13.0M | $10.8M | $10.0M | $8.2M | $8.2M | $8.2M | ||||
| Repayments Of Related Party Debt | $0.00 | $240.6K | $0.00 | ||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$71.0K | $3.9M | -$5.3M | $1.2M | |||||||||||||
| Temporary Equity Accretion To Redemption Value | $1.6M | $2.9M | $2.5M | $1.1M | $334.2K | $35.3M | |||||||||||
| Retained Earnings Accumulated Deficit | -$122.5M | -$125.7M | -$128.4M | -$123.9M | -$127.4M | -$111.8M | -$89.5M | -$12.7M | -$10.1M | -$9.1M | -$6.6M | -$6.2M | -$5.9M | ||||
| Prepaid Expense And Other Assets Current | $323.0K | $324.0K | $164.0K | $1.4M | $1.3M | $1.2M | $323.0K | $199.1K | $371.2K | $537.0K | $614.6K | $643.7K | $607.0K | ||||
| Liabilities And Stockholders Equity | $3.3M | $3.8M | $2.6M | $6.5M | $11.2M | $9.9M | $8.1M | $85.5M | $245.4M | $242.6M | $238.7M | $238.0M | $238.1M | ||||
| Assets Current | $2.8M | $3.3M | $2.0M | $6.5M | $11.0M | $9.6M | $5.6M | $356.5K | $787.1K | $935.7K | $1.4M | $1.6M | $1.8M | ||||
| Assets | $3.3M | $3.8M | $2.6M | $6.5M | $11.2M | $9.9M | $8.1M | $85.5M | $245.4M | $242.6M | $238.7M | $238.0M | $238.1M | ||||
| Liabilities Current | $18.1M | $21.9M | $24.5M | $21.8M | $22.9M | $23.1M | $9.4M | $866.8K | $420.2K | $889.0K | $145.1K | $106.8K | $136.7K | ||||
| Assets Held In Trust Noncurrent | $85.1M | $241.7M | $237.2M | $236.1M | $235.8M | ||||||||||||
| Offering Costs Included In Accounts Payable Accrued Expenses | $85.0K | $200.0K | |||||||||||||||
| Deferred Under Writing Fees Payable | $8.1M | $0.00 | |||||||||||||||
| Temporary Equity Carrying Amount Attributable To Parent | $85.1M | $244.6M | $241.7M | $237.2M | $236.1M | $235.8M | |||||||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||||
| Deferred Underwriting Fee Payable Non Current | $8.1M | $8.1M | $8.1M | $8.1M | $8.1M | $8.1M | |||||||||||
| Deferred Offering Costs Non Current | $0.00 | $0.00 | $0.00 | $1.9M | $0.00 | $0.00 | $0.00 | ||||||||||
| Accrued Offering Costs Current | $0.00 | $0.00 | $0.00 | $85.0K | $85.0K | $85.0K | |||||||||||
| Deferred Legal Fee Non Current | $2.4M | $940.0K | $460.0K | $28.0K | $10.0K | ||||||||||||
| Deferred Legal Fees Current | $2.6M | $2.6M | $2.7M | $3.0M | $3.3M | $0.00 | |||||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$143.0K | -$131.0K | -$123.0K | -$95.0K | -$83.0K | -$64.0K | -$49.0K | ||||||||||
| Accounts Payable Current | $12.2M | $13.9M | $14.0M | $13.1M | $11.6M | $9.3M | $6.5M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Share-Based Compensation * | $561.0K | $776.0K | |||
| Net Cash Provided By Used In Operating Activities | -$1.7M | -$18.1M | -$14.8M | -$1.9M | -$7.9K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$166.0K | $455.0K | -$192.0K | $588.8K | $2.0K |
| Net Cash Provided By Used In Financing Activities | $3.0M | $15.1M | $8.0M | $238.3M | $7.9K |
| Payments Of Stock Issuance Costs | $2.9M | $336.0K | $417.1K | $232.7K | |
| Net Cash Provided By Used In Investing Activities | -$34.0K | $161.0M | -$235.8M | $0.00 | |
| Proceeds From Related Party Debt | $8.3M | $75.00 | $240.6K | ||
| Proceeds From Issuance Of Private Placement | $0.00 | $13.6M | $0.00 | ||
| Proceeds From Issuance Of Common Stock | $0.00 | $6.2K | $0.00 | ||
| Proceeds From Issuance Initial Public Offering | $0.00 | $225.4M | $0.00 | ||
| Payments To Acquire Restricted Investments | $0.00 | $235.8M | $0.00 | ||
| Increase Decrease In Prepaid Insurance Non Current | -$24.5K | $24.5K | $0.00 | ||
| Increase Decrease In Accrued Liabilities | $854.6K | $30.3K | $0.00 | ||
| Increase Decrease In Deferred Legal Fee Payable | $3.9M | $160.0K | $0.00 | ||
| Increase Decrease In Accounts Payable | $198.0K | $7.1M | $3.5M | ||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -$53.0K | -$63.0K | -$21.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Share-Based Compensation * | $42.0K | $30.0K | $44.0K | $199.0K | $229.0K | $191.0K | $368.0K | $162.0K | $45.0K | ||
| Net Cash Provided By Used In Operating Activities | -$59.0K | -$2.1M | -$5.3M | -$1.3M | $0.00 | ||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$94.0K | $736.0K | $589.0K | $19.8K | $0.00 | ||||||
| Net Cash Provided By Used In Financing Activities | $6.1M | $6.0K | $238.3M | $0.00 | |||||||
| Payments Of Stock Issuance Costs | $1.5M | $0.00 | $417.1K | $160.4K | |||||||
| Net Cash Provided By Used In Investing Activities | -$11.0K | $0.00 | -$235.8M | $0.00 | |||||||
| Proceeds From Related Party Debt | $0.00 | $75.00 | $160.4K | ||||||||
| Proceeds From Issuance Of Private Placement | $0.00 | $13.6M | $0.00 | ||||||||
| Proceeds From Issuance Of Common Stock | $0.00 | $6.2K | $0.00 | ||||||||
| Proceeds From Issuance Initial Public Offering | $0.00 | $225.4M | $0.00 | ||||||||
| Payments To Acquire Restricted Investments | $0.00 | $235.8M | $0.00 | ||||||||
| Increase Decrease In Prepaid Insurance Non Current | -$24.5K | $464.9K | $0.00 | ||||||||
| Increase Decrease In Accrued Liabilities | $857.1K | $51.7K | $0.00 | ||||||||
| Increase Decrease In Deferred Legal Fee Payable | $300.0K | $0.00 | |||||||||
| Increase Decrease In Accounts Payable | $48.0K | $2.1M | $635.0K | ||||||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -$12.0K | -$19.0K | $5.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Preferred Stock Shares Authorized | 5.0M | 5.0M | |||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | ||
| Earnings Per Share Diluted | $0.04 | $-1.30 | $-5.82 | ||
| Earnings Per Share Basic | $0.09 | $-1.30 | $-5.82 | ||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | ||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | ||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | |||
| Weighted Average Number Of Shares Outstanding Basic | 101.9M | 29.4M | |||
| Weighted Average Number Of Diluted Shares Outstanding | 227.4M | 29.4M | |||
| Common Stock Shares Outstanding | 172.3M | 43.6M | |||
| Common Stock Shares Issued | 172.3M | 43.6M | |||
| Common Stock Shares Authorized | 600.0M | 600.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Preferred Stock Shares Authorized | 13.0K | 14.6M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | ||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||
| Earnings Per Share Diluted | $0.02 | $0.04 | $-0.02 | $0.09 | $-0.48 | $-4.09 | $-1.15 | $-1.01 | $-1.09 | |||||
| Earnings Per Share Basic | $0.03 | $0.05 | $-0.02 | $0.09 | $-0.48 | $-4.09 | $-1.15 | $-1.01 | $-1.09 | |||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||
| Weighted Average Number Of Shares Outstanding Basic | 96.2M | 51.8M | 42.5M | 39.4M | 32.2M | 5.5M | 4.7M | 4.7M | 4.7M | |||||
| Weighted Average Number Of Diluted Shares Outstanding | 214.8M | 66.3M | 42.5M | 39.4M | 32.2M | 5.5M | 4.7M | 4.7M | 4.7M | |||||
| Common Stock Shares Outstanding | 101.1M | 93.0M | 43.6M | 43.0M | 35.3M | 29.1M | 4.7M | |||||||
| Common Stock Shares Issued | 101.1M | 93.0M | 43.6M | 43.0M | 35.3M | 29.1M | 4.7M | |||||||
| Common Stock Shares Authorized | 600.0M | 600.0M | 600.0M | 600.0M | 600.0M | 600.0M | 23.5M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Investment Income Interest | $8.2M | $3.4M | $0.00 | ||
| Formationprofessional Feesandgeneral And Administrativecosts | $8.3M | $1.5M | $10.9K | ||
| Additional Paid In Capital | $110.2M | $104.3M | $0.00 | $24.4K | |
| Cumulative Translation Adjustment Net Of Tax Period Increase Decrease | -$53.0K | -$60.0K | -$24.0K | ||
| Accretion Of Classa Shares To Redemption Value | 0.00 | 3.4M | 0.00 | ||
| Fair Value Of Founder Shares In Excess Attributable To Anchor Investor | 0.00 | 10.4M | 0.00 | ||
| Foreign Currency Translation Adjustment | -$53.0K | -$60.0K | -$24.0K | ||
| Change In Fair Value Of Convertible Promissory Notes Related Party | $599.2K | $0.00 | |||
| Prepaid Insurance Non Current | $0.00 | $24.5K | $0.00 | ||
| Stock Issued During Period Value Stock Options Exercised | $68.0K | $37.0K | |||
| Remeasurement Of Class A Ordinary Shares Redemption Amount | 8.2M | 35.3M | 0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment Income Interest | $1.6M | $2.9M | $2.5M | $1.1M | $312.5K | $21.8K | $0.00 | |||||||||
| Formationprofessional Feesandgeneral And Administrativecosts | $2.7M | $1.3M | $2.3M | $386.9K | $360.0K | $298.2K | $225.00 | $4.2K | $5.0K | |||||||
| Additional Paid In Capital | $106.6M | $106.5M | $104.3M | $104.2M | $100.5M | $90.8M | $14.6M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Cumulative Translation Adjustment Net Of Tax Period Increase Decrease | -$12.0K | -$8.0K | -$14.0K | -$12.0K | -$19.0K | -$15.0K | -$8.0K | -$6.0K | -$1.0K | |||||||
| Accretion Of Classa Shares To Redemption Value | 2.5M | 0.00 | 0.00 | |||||||||||||
| Fair Value Of Founder Shares In Excess Attributable To Anchor Investor | 10.4M | 0.00 | ||||||||||||||
| Foreign Currency Translation Adjustment | -$12.0K | -$8.0K | -$14.0K | -$12.0K | -$19.0K | -$15.0K | -$8.0K | -$6.0K | -$1.0K | |||||||
| Change In Fair Value Of Convertible Promissory Notes Related Party | $22.2K | $15.4K | $608.00 | $0.00 | $0.00 | $0.00 | ||||||||||
| Prepaid Insurance Non Current | $0.00 | $0.00 | $0.00 | $171.3K | $318.1K | $464.9K | ||||||||||
| Stock Issued During Period Value Stock Options Exercised | $68.0K | $20.0K | $3.0K | $6.0K | ||||||||||||
| Remeasurement Of Class A Ordinary Shares Redemption Amount |
Most recent annual filing with the SEC: March 31, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.